Legend Biotech Corp. (LEGN)
20.94
-0.88
(-4.03%)
USD |
NASDAQ |
Aug 24, 16:00
21.31
+0.37
(+1.77%)
After-Hours: 20:00
Legend Biotech Shareholders Equity (Quarterly) : 1.230B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.230B |
| March 31, 2026 | 967.73M |
| December 31, 2025 | 1.002B |
| September 30, 2025 | 1.011B |
| June 30, 2025 | 1.036B |
| March 31, 2025 | 1.018B |
| December 31, 2024 | 1.041B |
| September 30, 2024 | 1.116B |
| June 30, 2024 | 1.159B |
| March 31, 2024 | 1.164B |
| December 31, 2023 | 1.251B |
| September 30, 2023 | 1.340B |
| June 30, 2023 | 1.407B |
| March 31, 2023 | 653.16M |
| Date | Value |
|---|---|
| December 31, 2022 | 744.31M |
| September 30, 2022 | |
| June 30, 2022 | 562.63M |
| March 31, 2022 | 741.16M |
| December 31, 2021 | 765.94M |
| September 30, 2021 | 225.87M |
| June 30, 2021 | 339.92M |
| March 31, 2021 | 206.46M |
| December 31, 2020 | 597.77M |
| September 30, 2020 | 334.90M |
| June 30, 2020 | 401.00M |
| March 31, 2020 | -166.33M |
| December 31, 2019 | -122.87M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -5.935B |
| Dianthus Therapeutics, Inc. | 1.172B |
| Gilead Sciences, Inc. | 11.83B |
| Ironwood Pharmaceuticals, Inc. | -161.84M |
| Arbutus Biopharma Corp. | 258.73M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.751B |
| Total Liabilities (Quarterly) | 521.32M |
| Debt to Equity Ratio | 0.2263 |
| Current Ratio | 3.041 |
| Net Debt Paydown Yield | 0.30% |